United Kingdom based
Omnia Biosystems’ is a London-based biotech startup whose goal is to create a smart peptide therapeutics discovery system driven by neural networks to optimize time & financial spends. Inspired by computer-aided drug design, Omnia develops AI-based molecular drug design and currently has four candidates in the pipeline – three of them against various types of cancer and one designed to activate T cells.
TechnologiesAI Companies (Drug Discovery)
Companion Diagnostic for T Cell Activation
No services posted yet